Albert Pinhasov Selected Research

Albert Pinhasov Research Topics

Disease

5	Inflammation (Inflammations) 06/2022 - 03/2003
5	Neoplasms (Cancer) 06/2022 - 09/2016
3	Melanoma (Melanoma, Malignant) 09/2021 - 09/2016
3	Body Weight (Weight, Body) 01/2021 - 01/2012
2	Medulloblastoma 05/2021 - 01/2018
2	Mood Disorders (Mood Disorder) 01/2020 - 11/2008
2	Atopic Dermatitis (Atopic Eczema) 01/2020 - 12/2017
1	Infections 06/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 05/2021
1	Animal Diseases 01/2021
1	Paranoid Disorders (Paranoia) 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 11/2019
1	Splenomegaly 11/2019
1	Carcinogenesis 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2017
1	Dermatitis 12/2017
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 07/2016
1	Muscular Dystrophies (Muscular Dystrophy) 07/2016
1	Polydipsia 02/2016
1	Cognitive Dysfunction 05/2015
1	Major Depressive Disorder (Major Depressive Disorders) 01/2015
1	Coma (Comas) 10/2012
1	Heat Stroke (Heatstroke) 10/2012
1	Depressive Disorder (Melancholia) 01/2011
1	Confusion (Bewilderment) 01/2007
1	Parkinson Disease (Parkinson's Disease) 01/2006
1	Fetal Alcohol Spectrum Disorders 06/2004
1	Fetal Death 06/2004
1	Craniocerebral Trauma (Head Injury) 03/2003
1	Colonic Neoplasms (Colon Cancer) 10/2002
1	Lung Neoplasms (Lung Cancer) 10/2002

Drug/Important Bio-Agent (IBA)

4	Peptides (Polypeptides)IBA 01/2017 - 03/2003
3	Cyclic PeptidesIBA 06/2022 - 01/2017
3	IntegrinsIBA 09/2021 - 09/2016
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2017 - 11/2008
3	Antidepressive Agents (Antidepressants)IBA 01/2015 - 01/2007
2	CytokinesIBA 06/2022 - 11/2019
2	RNA (Ribonucleic Acid)IBA 05/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 05/2021 - 01/2018
2	CannabinoidsIBA 01/2020 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2018 - 03/2003
2	Pharmaceutical PreparationsIBA 01/2017 - 01/2007
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2011 - 11/2008
1	ChemokinesIBA 06/2022
1	InterferonsIBA 06/2022
1	Tumor Biomarkers (Tumor Markers)IBA 09/2021
1	Connexin 30IBA 05/2021
1	Metalloproteases (Metalloproteinases)IBA 05/2021
1	AdipokinesIBA 01/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	Immunoglobulin E (IgE)IBA 01/2020
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Insulin (Novolin)FDA Link 11/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	alanyl-glycyl-serineIBA 01/2017
1	hydroxide ionIBA 01/2017
1	Topoisomerase I InhibitorsIBA 01/2017
1	Amino Acids FDA Link 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2017
1	CamptothecinIBA 01/2017
1	leucyl-phenylalanineIBA 01/2017
1	Sucrose (Saccharose)IBA 02/2016
1	AcidsIBA 05/2015
1	RimonabantIBA 01/2012
1	Nerve Growth Factors (Neurotrophins)IBA 11/2008
1	Antimanic AgentsIBA 01/2007
1	SynucleinsIBA 01/2006
1	Proteins (Proteins, Gene)FDA Link 01/2006
1	ApolipoproteinsIBA 06/2004
1	SALLRSIPAIBA 06/2004
1	Neuroprotective AgentsIBA 03/2003
1	stearyl- Nle(17)- neurotensin(6- 11)VIP(7- 28)IBA 10/2002
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 10/2002
1	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 10/2002

Therapy/Procedure

2	Injections 09/2016 - 03/2003
1	Radiotherapy 05/2021
1	Therapeutics 01/2021
1	Ligation 07/2016
1	General Anesthesia 10/2012
1	Emergency Treatment 10/2012
1	Aftercare (After-Treatment) 06/2004